Cardiovascular outcome trials for anti-diabetes medication: A holy grail of drug development?
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference53 articles.
1. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association;Fox;Diabetes Care,2015
2. Executive summary: heart disease and stroke statistics – 2013 update: a report from the American Heart Association;Go;Circulation,2013
3. Effect of a multifactorial intervention on mortality in type 2 diabetes;Gaede;N Engl J Med,2008
4. Is the combination of sulfonylureas and metformin associated with an increased risk of cardiovascular disease or all-cause mortality?: a meta-analysis of observational studies;Rao;Diabetes Care,2008
5. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes;Nissen;N Engl J Med,2007
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Methodology of clinical trials on sodium-glucose cotransporter 2 inhibitors registered on ClinicalTrials.gov: a cross-sectional study;BMC Medical Research Methodology;2024-07-30
2. Safety‐Related Drug Label Changes Following Large Post‐Marketing Cardiometabolic Trials: A Review of European Public Assessment Reports;Clinical Pharmacology & Therapeutics;2023-01-18
3. Necessity of Baseline Diabetic Autonomic Neuropathy Screening to Start Cardiovascular Safety Outcome Trials: A Focus on Antidiabetic Agents and Autonomic Neurointegrity;Bengal Physician Journal;2022-04-01
4. Cardiovascular safety outcomes of once‐weekly GLP‐1 receptor agonists in people with type 2 diabetes;Journal of Clinical Pharmacy and Therapeutics;2020-09
5. Modern sulphonylureas and cardiovascular adverse effects: Will CAROLINA put an end to the controversy?;Indian Heart Journal;2020-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3